Identification of potential biomarkers of P-glycoprotein substrate neurotoxicity in transgenic mice expressing the mutated canine ABCB1 gene
Search for other papers by Min Zhu in
Current site
Google Scholar
PubMed
Search for other papers by Yi Ming in
Current site
Google Scholar
PubMed
Search for other papers by Heidi Swaim in
Current site
Google Scholar
PubMed
Search for other papers by Marla D. Swain in
Current site
Google Scholar
PubMed
Search for other papers by Michael J. Myers in
Current site
Google Scholar
PubMed
Search for other papers by Christine Deaver in
Current site
Google Scholar
PubMed
Search for other papers by Xiaolin Wu in
Current site
Google Scholar
PubMed
Search for other papers by Yolanda L. Jones in
Current site
Google Scholar
PubMed
Search for other papers by Haile F. Yancy in
Current site
Google Scholar
PubMed
Abstract
Objective—To identify biomarkers of P-glycoprotein (P-gp) substrate neurotoxicity in transgenic mice expressing the mutant canine ABCB1 gene (ABCB1-1Δ).
Animals—8 ABCB1 knock-in and knock-out transgenic mice expressing the ABCB1-1Δ gene and 8 control mice expressing the wild-type canine ABCB1 gene (ABCB1-WT).
Procedures—Groups including 2 ABCB1-1Δ mutant mice and 2 ABCB1-WT mice were administered the P-gp substrates ivermectin (10 mg/kg, SC), doramectin (10 mg/kg, SC), moxidectin (10 mg/kg, PO), or digoxin (1.53 mg/kg, SC). A toxicogenomic approach based on DNA microarrays was used to examine whole-genome expression changes in mice administered P-gp substrates.
Results—Compared with control ABCB1-WT mice, ABCB1-1Δ mutant mice developed neurotoxic signs including ataxia, lethargy, and tremors similar to those reported for dogs with the ABCB1-1Δ mutation. Microarray analysis revealed that gene expression was altered in ABCB1-1Δ mutant mice, compared with findings for ABCB1-WT mice, following administration of the same P-gp substrates. Gene pathway analysis revealed that genes with a ≥ 2-fold gene expression change were associated with behavior and nervous system development and function. Moreover, 34 genes were altered in the ABCB1-1Δ mutant mice in all 4 drug treatment groups. These genes were also associated with behavior, which was identified as the top-ranked gene network.
Conclusions and Clinical Relevance—These study data have facilitated understanding of the molecular mechanisms of neurotoxicosis in ABCB1-1Δ mutant mice following exposure to various P-gp substrates. Some genes appear to be potential biomarkers of P-gp substrate neurotoxicity that might be used to predict the safety of those drugs in dogs with the ABCB1-1Δ mutation.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 112 | 0 | 0 |
| Full Text Views | 38767 | 37469 | 143 |
| PDF Downloads | 256 | 113 | 2 |
